These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 23167829)
1. Inhibitor-induced conformational shifts and ligand-exchange dynamics for HIV-1 protease measured by pulsed EPR and NMR spectroscopy. Huang X; de Vera IM; Veloro AM; Blackburn ME; Kear JL; Carter JD; Rocca JR; Simmerling C; Dunn BM; Fanucci GE J Phys Chem B; 2012 Dec; 116(49):14235-44. PubMed ID: 23167829 [TBL] [Abstract][Full Text] [Related]
2. Conformational landscape of non-B variants of HIV-1 protease: A pulsed EPR study. Tran TT; Liu Z; Fanucci GE Biochem Biophys Res Commun; 2020 Nov; 532(2):219-224. PubMed ID: 32863004 [TBL] [Abstract][Full Text] [Related]
3. Monitoring inhibitor-induced conformational population shifts in HIV-1 protease by pulsed EPR spectroscopy. Blackburn ME; Veloro AM; Fanucci GE Biochemistry; 2009 Sep; 48(37):8765-7. PubMed ID: 19691291 [TBL] [Abstract][Full Text] [Related]
4. Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts. Liu Z; Casey TM; Blackburn ME; Huang X; Pham L; de Vera IM; Carter JD; Kear-Scott JL; Veloro AM; Galiano L; Fanucci GE Phys Chem Chem Phys; 2016 Feb; 18(8):5819-31. PubMed ID: 26489725 [TBL] [Abstract][Full Text] [Related]
5. Solution structure of HIV-1 protease flaps probed by comparison of molecular dynamics simulation ensembles and EPR experiments. Ding F; Layten M; Simmerling C J Am Chem Soc; 2008 Jun; 130(23):7184-5. PubMed ID: 18479129 [TBL] [Abstract][Full Text] [Related]
6. Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease. Casey TM; Fanucci GE Methods Enzymol; 2015; 564():153-87. PubMed ID: 26477251 [TBL] [Abstract][Full Text] [Related]
7. Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA-approved inhibitors: MD study. Maphumulo SI; Halder AK; Govender T; Maseko S; Maguire GEM; Honarparvar B; Kruger HG Chem Biol Drug Des; 2018 Nov; 92(5):1899-1913. PubMed ID: 30003668 [TBL] [Abstract][Full Text] [Related]
8. Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility. Kear JL; Blackburn ME; Veloro AM; Dunn BM; Fanucci GE J Am Chem Soc; 2009 Oct; 131(41):14650-1. PubMed ID: 19788299 [TBL] [Abstract][Full Text] [Related]
9. Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease. de Vera IM; Smith AN; Dancel MC; Huang X; Dunn BM; Fanucci GE Biochemistry; 2013 May; 52(19):3278-88. PubMed ID: 23566104 [TBL] [Abstract][Full Text] [Related]
10. Natural Polymorphisms D60E and I62V Stabilize a Closed Conformation in HIV-1 Protease in the Absence of an Inhibitor or Substrate. Tran TT; Fanucci GE Viruses; 2024 Feb; 16(2):. PubMed ID: 38400012 [TBL] [Abstract][Full Text] [Related]
11. Drug pressure selected mutations in HIV-1 protease alter flap conformations. Galiano L; Ding F; Veloro AM; Blackburn ME; Simmerling C; Fanucci GE J Am Chem Soc; 2009 Jan; 131(2):430-1. PubMed ID: 19140783 [TBL] [Abstract][Full Text] [Related]
12. Dynamics of "flap" structures in three HIV-1 protease/inhibitor complexes probed by total chemical synthesis and pulse-EPR spectroscopy. Torbeev VY; Raghuraman H; Mandal K; Senapati S; Perozo E; Kent SB J Am Chem Soc; 2009 Jan; 131(3):884-5. PubMed ID: 19117390 [TBL] [Abstract][Full Text] [Related]
13. Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors. Li D; Liu MS; Ji B; Hwang K; Huang Y J Chem Phys; 2009 Jun; 130(21):215102. PubMed ID: 19508101 [TBL] [Abstract][Full Text] [Related]
14. A synergy of activity, stability, and inhibitor-interaction of HIV-1 protease mutants evolved under drug-pressure. Khan SN; Persons JD; Guerrero M; Ilina TV; Oda M; Ishima R Protein Sci; 2021 Mar; 30(3):571-582. PubMed ID: 33314454 [TBL] [Abstract][Full Text] [Related]
16. Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis. Karnati KR; Wang Y J Mol Graph Model; 2019 Nov; 92():112-122. PubMed ID: 31351319 [TBL] [Abstract][Full Text] [Related]
17. Pressure-induced structural transition of mature HIV-1 protease from a combined NMR/MD simulation approach. Roche J; Louis JM; Bax A; Best RB Proteins; 2015 Dec; 83(12):2117-23. PubMed ID: 26385843 [TBL] [Abstract][Full Text] [Related]
18. Three-dimensional structure of a mutant HIV-1 protease displaying cross-resistance to all protease inhibitors in clinical trials. Chen Z; Li Y; Schock HB; Hall D; Chen E; Kuo LC J Biol Chem; 1995 Sep; 270(37):21433-6. PubMed ID: 7665551 [TBL] [Abstract][Full Text] [Related]
19. The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamics. Huang X; Britto MD; Kear-Scott JL; Boone CD; Rocca JR; Simmerling C; Mckenna R; Bieri M; Gooley PR; Dunn BM; Fanucci GE J Biol Chem; 2014 Jun; 289(24):17203-14. PubMed ID: 24742668 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the molecular dynamics and calculated binding free energies for nine FDA-approved HIV-1 PR drugs against subtype B and C-SA HIV PR. Ahmed SM; Kruger HG; Govender T; Maguire GE; Sayed Y; Ibrahim MA; Naicker P; Soliman ME Chem Biol Drug Des; 2013 Feb; 81(2):208-18. PubMed ID: 23017010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]